Quantbot Technologies’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,900
Closed -$78K 1451
2020
Q4
$78K Buy
+2,900
New +$65.1K 0.01% 791
2018
Q4
Sell
-3,528
Closed -$99K 1066
2018
Q3
$99K Buy
3,528
+3,076
+681% +$88.4K 0.01% 876
2018
Q2
$12K Sell
452
-3,688
-89% -$110K ﹤0.01% 1104
2018
Q1
$130K Buy
+4,140
New +$131K 0.01% 785
2015
Q3
Sell
-961
Closed -$34K 1228
2015
Q2
$34K Buy
+961
New +$33.7K 0.01% 876

Other funds holding CLLS

Quantbot Technologies's CLLS Position: Q1 2021 in Review

Quantbot Technologies sold out of Cellectis (CLLS) in Q1 2021, closing a stake of 2,900 shares — an estimated $78K sold.

Quantbot Technologies first reported a position in CLLS in Q2 2015 and held it in 5 quarters. The position peaked at $130K in Q1 2018. 81 funds tracked by Wall St. Rank hold CLLS as of Q1 2021.

  • Quantbot Technologies reported no remaining Cellectis position as of Q1 2021 after selling out during the quarter.
  • Quantbot Technologies sold 2,900 Cellectis shares in Q1 2021, an estimated $78K.
  • Quantbot Technologies first reported a position in Cellectis in Q2 2015 and held it in 5 quarters.
  • Quantbot Technologies's Cellectis position peaked at $130K in Q1 2018.
  • 81 funds tracked by Wall St. Rank held Cellectis as of Q1 2021.

Based on Quantbot Technologies's 13F filing for Q1 2021, filed 14 May 2021.